| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Article
Korean J Clin Oncol. 2009;5(1): 36-39.         doi: https://doi.org/10.14216/kjco.09007
Long-term survival with Gemcitabine alone chemotherapy for non-metastatic advanced pancreatic cancer ; One case
Hyung Ook Kim, Hungdai Kim, Jun Ho Shin
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
비전이성 진행 췌장암에서 Gemcitabine 단독 항암 화학요법을 통한 장기 생존 1예
김형욱, 김흥대, 신준호
성균관대학교 의과대학 강북삼성병원 외과학교실
Corresponding Author: Jun Ho Shin ,Tel: +82-2-2001-2138, Fax: +82-2-2001-2131, Email: junho0521.shin@samsung.com
Received: April 10, 2009;  Accepted: May 7, 2009.
Share :  
We report a 69-year-old male patient with non-metastatic advanced pancreatic cancer confirmed by abdominal computed tomography and intraoperative biopsy. He presented with long-term survival more than 30 months without disease progression or complication following palliative surgery and chemotherapy, after palliative choledochojejunostomy and postoperative gemcitabine alone chemotherapy.
Keywords: Pancreatic cancer | Obstructive jaundice | Palliation
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@daum.net

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers